Subjective cognitive decline (SCD) manifesting before clinical impairment could serve as a target population for early intervention trials in Alzheimer’s disease (AD). A working group, the Subjective Cognitive Decline Initiative (SCD-I), published SCD research criteria in the context of preclinical AD. To successfully apply them, a number of issues regarding assessment and implementation of SCD needed to be addressed.
from Dementia Big http://ift.tt/2eKG1BK via alcoholic dementia
http://ift.tt/2eEeBzN
No comments:
Post a Comment